Answer
Fewer than 5% of patients treated with dornase alfa have developed antibodies to it, with none of these patients developing IgE antibodies to dornase alfa.
Sources for this answer
- Pulmozyme 2500 U/ 2.5ml, nebuliser solutionRoche Products Limited · emc · SmPC §4.8 Undesirable effects · Version 12Document updated
Sources checked